It is appropriate to set out, as a fourth measure, that a potential registrant who pre-registered a phase-in substance in accordance with Article 28 of Regulation (EC) No 1907/2006 should, until the specified cut-off date, not be required to follow the inquiry process set out in Article 26 of that Regulation because the objective of the inquiry process has already been fulfilled through the pre-registration.
Recital 6, Regulation (EU) 2019/1692
In forcesince 9 Oct 2019